secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vor Biopharma Inc. (VOR)
CIK:        0001817229
Form:       8-K
Filed at:   2025-07-10T23:59:59+00:00
Accession:  0001193125-25-157638
Event type: leadership
Sentiment:  positive
Materiality: 0.65
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vor Biopharma appoints Sandesh Mahatme as CFO and Chief Business Officer
------------------------------------------------------------------------

- Sandesh Mahatme appointed CFO, Principal Financial Officer and Principal Accounting Officer, effective July 9, 2025.
- Mahatme previously served as President, COO and CFO of National Resilience Inc., raising over $2.5B in capital.
- His initial base salary is $480,000, with a 40% target bonus and a $274,000 signing bonus.
- Received a grant of 13,882,750 RSUs under the 2023 Inducement Plan; severance includes 12–18 months base salary.
- Mahatme also joins as Chief Business Officer, bringing experience from Sarepta and Celgene.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1817229/000119312525157638/0001193125-25-157638-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1817229/000119312525157638/d933755d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-157638

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer